novel muscle disorders
models of muscle disorders
skeletal muscle disorders
novel therapeutic targets of muscle disorders
drug screening
novel therapeutic strategies
validation of drug candidates
relevant stakeholders
pharmaceutical drug discovery research
human relevant disease models
relevant functional unit
lack of therapeutic options
ultimate aim of MUSCLEGUY
pharmaceutical industry
lack of reliable
HTS format
matured myofibers
product
elaborate market analysis
requirements
potential
number of animals
strong IP portfolio
business plan
reality
associated costs
majority of patients
unique opportunity
huge socioeconomic burden
commercial feasibility
systems
addition